-
2
-
-
0024696043
-
Bacterial resistance to quinolones: Mechanisms and clinical importance
-
Wolfson JS, Hooper DC. Bacterial resistance to quinolones: mechanisms and clinical importance. Rev Infect Dis 1989;11:S960-S968.
-
(1989)
Rev Infect Dis
, vol.11
-
-
Wolfson, J.S.1
Hooper, D.C.2
-
3
-
-
0025029336
-
Development of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin
-
Radberg G, Nilsson LE, Svensson S. Development of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin. Antimicrob Agents Chemother 1990;34:2142-2147.
-
(1990)
Antimicrob Agents Chemother
, vol.34
, pp. 2142-2147
-
-
Radberg, G.1
Nilsson, L.E.2
Svensson, S.3
-
4
-
-
0026719282
-
Antimicrobial activity of DU6859a, a new potent fluoroquinolone, against clinical isolates
-
Sato K, Hoshino K, Tanaka M, Hayakawa I, Osada Y. Antimicrobial activity of DU6859a, a new potent fluoroquinolone, against clinical isolates. Antimicrob Agents Chemother 1992;36:1491-1498.
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 1491-1498
-
-
Sato, K.1
Hoshino, K.2
Tanaka, M.3
Hayakawa, I.4
Osada, Y.5
-
5
-
-
0026780231
-
Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation
-
Matsumoto M, Kojima K, Nagano H, Matsumoto S, Yokota T. Photostability and biological activity of fluoroquinolones substituted at the 8 position after UV irradiation. Antimicrob Agents Chemother 1992;36:1715-1719.
-
(1992)
Antimicrob Agents Chemother
, vol.36
, pp. 1715-1719
-
-
Matsumoto, M.1
Kojima, K.2
Nagano, H.3
Matsumoto, S.4
Yokota, T.5
-
6
-
-
0026563036
-
Adverse effects of fluoroquinolones
-
Shimada J, Hori S. Adverse effects of fluoroquinolones. Prog Drug Res 1992;38:133-143.
-
(1992)
Prog Drug Res
, vol.38
, pp. 133-143
-
-
Shimada, J.1
Hori, S.2
-
7
-
-
0022374762
-
The fluoroquinolones: Pharmacology, clinical uses, and toxicities in humans
-
Hooper, DC, Wolfson JS. The fluoroquinolones: pharmacology, clinical uses, and toxicities in humans. Antimicrob Agents Chemother 1985;28:716-721.
-
(1985)
Antimicrob Agents Chemother
, vol.28
, pp. 716-721
-
-
Hooper, D.C.1
Wolfson, J.S.2
-
8
-
-
0028227016
-
Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily
-
Sha J, Kaiser LL, Echols R, Heller AH. Comparative pharmacokinetics and safety of ciprofloxacin 400 mg iv thrice daily versus 750 mg po twice daily. J Antimicrob Chemother 1994;33:795-801.
-
(1994)
J Antimicrob Chemother
, vol.33
, pp. 795-801
-
-
Sha, J.1
Kaiser, L.L.2
Echols, R.3
Heller, A.H.4
-
9
-
-
0026556709
-
Fluoroquinolone resistance, an evolving national problem or just a problem for some physicians?
-
Jones RN. Fluoroquinolone resistance, an evolving national problem or just a problem for some physicians? Diagn Microbiol Infect Dis 1992;15:177-179.
-
(1992)
Diagn Microbiol Infect Dis
, vol.15
, pp. 177-179
-
-
Jones, R.N.1
-
10
-
-
0002160117
-
The fluoroquinolones: Clinical and laboratory considerations
-
Wolfson JS, Hooper DC. The fluoroquinolones: clinical and laboratory considerations. Clin Microbiol Rev 1992;14:1-7.
-
(1992)
Clin Microbiol Rev
, vol.14
, pp. 1-7
-
-
Wolfson, J.S.1
Hooper, D.C.2
-
11
-
-
34249760938
-
Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993-1995
-
Ubukata K, Asahi Y, Okuzumi K, Konno M, the Working Group for Penicillin-Resistant 5. Pneumoniae. Incidence of penicillin-resistant Streptococcus pneumoniae in Japan, 1993-1995. J Infect Chemother 1996;1:177-184.
-
(1996)
J Infect Chemother
, vol.1
, pp. 177-184
-
-
Ubukata, K.1
Asahi, Y.2
Okuzumi, K.3
Konno, M.4
-
12
-
-
0041396064
-
DU6859a, a new quinolone: Therapeutic efficacy on experimental pneumonia due to Pseudomonas aeruginosa and Streptococcus pneumoniae
-
Washington DC: American Society for Microbiology, abstr
-
Ishida Y, Otani T, Ohashi M, Someya K, Yoshida K, Hayakawa I, et al. DU6859a, a new quinolone: therapeutic efficacy on experimental pneumonia due to Pseudomonas aeruginosa and Streptococcus pneumoniae. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1993;302 (abstr).
-
(1993)
Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy
, vol.302
-
-
Ishida, Y.1
Otani, T.2
Ohashi, M.3
Someya, K.4
Yoshida, K.5
Hayakawa, I.6
-
13
-
-
85030002777
-
In vitro postantibiotic effect, pharmacokinetics in mice, and in vivo effective regrowth time of a new quinolone, DU6859a
-
Washington DC: American Society for Microbiology, abstr
-
Totsuka K, Shimizu K. In vitro postantibiotic effect, pharmacokinetics in mice, and in vivo effective regrowth time of a new quinolone, DU6859a. In: Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington DC: American Society for Microbiology, 1993;302 (abstr).
-
(1993)
Program and Abstracts of the 33rd Interscience Conference on Antimicrobial Agents and Chemotherapy
, vol.302
-
-
Totsuka, K.1
Shimizu, K.2
-
14
-
-
0029039624
-
In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem
-
Asahi Y, Miyazaki, S, Yamaguchi K. In vitro and in vivo antibacterial activities of BO-2727, a new carbapenem. Antimicrob Agents Chemother 1995;39:1030-1037.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, pp. 1030-1037
-
-
Asahi, Y.1
Miyazaki, S.2
Yamaguchi, K.3
|